Did advice on the prescription of sodium valproate reduce prescriptions to women? An observational study in three European countries between 2007 and 2016.

Rachel CharltonChristine Damase-MichelCaroline Hurault-DelarueRosa GiniMaria LoaneAnna PieriniAurora PucciniAmanda NevilleJulia SnowballJoan K Morrisnull null

Published in: Pharmacoepidemiology and drug safety (2019)

There is evidence that the CMDh warning did lead to changes in prescription patterns of sodium valproate in women of childbearing age. There were considerable differences in prescribing practice amongst regions of Europe.

Keyphrases

polycystic ovary syndrome
primary care
pregnancy outcomes
cervical cancer screening
breast cancer risk
pregnant women
insulin resistance
metabolic syndrome
quality improvement